Literature DB >> 30197187

Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study.

Anna Chiara Piscaglia1, Loris Riccardo Lopetuso2, Lucrezia Laterza2, Viviana Gerardi2, Elena Sacchini3, Emanuele Leoncini4, Stefania Boccia4, Maria Loredana Stefanelli5, Antonio Gasbarrini2, Alessandro Armuzzi6.   

Abstract

BACKGROUND: The burden of Crohn's disease (CD) and ulcerative colitis (UC) has never been estimated in the Republic of San Marino, the third smallest nation of the world. AIMS: To assess the occurrence and clinical features of CD and UC in San Marino during the last 35 years.
METHODS: We retrospectively evaluated the prevalence, incidence, and main clinical aspects of CD and UC from 1980 to 2014, crossing data from various sources.
RESULTS: Prevalence rates (per 100,000) on December 31, were 241 for CD (263 in males and 220 in females) and 311 for UC (370 in males and 255 in females). The specific incidence of UC steadily increased from 4.6 (95% CI: 1.5-10.6) in 1980-1984 to 12.4 (95% CI: 7.6-19.1) in 2010-2014; CD incidence showed a higher proportional increase, from 1.8 (95% CI: 0.2-6.6) in 1980-1984 to 17.9 (95% CI: 12.0-25.7) in 2010-2014. The main clinical features of CD and UC (activity and location at diagnosis, extra-intestinal manifestations, disease progression overtime, therapies, and hospitalizations) were analyzed.
CONCLUSIONS: This study provides the first epidemiological report on CD and UC in San Marino, showing specific traits and overall higher prevalence and incidence rates than previously reported in neighbor Areas.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Crohn’s disease; Incidence; Prevalence; Ulcerative colitis

Mesh:

Year:  2018        PMID: 30197187     DOI: 10.1016/j.dld.2018.08.016

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

1.  Population-based incidence and prevalence of inflammatory bowel diseases in Milan (Northern Italy), and estimates for Italy.

Authors:  Emanuele Crocetti; Walter Bergamaschi; Antonio Giampiero Russo
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

2.  A real world investigation on prevalence, clinical features, and therapy of inflammatory bowel disease in the city of Messina, Italy.

Authors:  Alessandra Belvedere; Riccardo Scoglio; Anna Viola; Giuseppe Costantino; Aldo Sitibondo; Marco Muscianisi; Santi Inferrera; Angela Alibrandi; Walter Fries
Journal:  Acta Biomed       Date:  2021-05-12

3.  Efficacy and safety of bifid triple viable plus aminosalicylic acid for the treatment of ulcerative colitis: A systematic review and meta-analysis.

Authors:  Mu-Yuan Chen; Zhen-Wen Qiu; Hong-Mei Tang; Kun-Hai Zhuang; Qing-Qun Cai; Xin-Lin Chen; Hui-Biao Li
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.